Ignite Creation Date:
2024-05-06 @ 7:02 PM
Last Modification Date:
2024-10-26 @ 2:59 PM
Study NCT ID:
NCT05872009
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-05-23
First Post:
2023-03-08
Brief Title:
Gestational Diabetes Mellitus Placental-maternal Crosstalk and Future Health
Sponsor:
Oslo University Hospital
Organization:
Oslo University Hospital
Study Overview
Official Title:
The GaP Study Gestational Diabetes Mellitus Placental-maternal Crosstalk and Future Health
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
GaP
Brief Summary:
The GaP study is designed to close important knowledge gaps by
1 exploring placental health and cellular ageing in GDM and the association with neonatal outcome
2 evaluating the effectiveness of current and novel maternal health follow-up strategies after GDM
1 exploring placental health and cellular ageing in GDM and the association with neonatal outcome
2 evaluating the effectiveness of current and novel maternal health follow-up strategies after GDM
Detailed Description:
The incidence of gestational diabetes mellitus GDM is increasing GDM has potential adverse short and long term health effects for both the women and her offspring and involves dysfunctional interaction between placenta and the maternal body The burden for the individual the health system and society warrants further investigations into the placental-maternal crosstalk in GDM in order to improve personalized pregnancy surveillance and follow-up In Oslo county nearly twice as many women who give birth suffer from GDM 57 than from preeclampsia 23 The large obstetric department at Ullevål provides an optimal environment for novel translational studies and clinical practical aspects of GDM The GaP study is designed to close important knowledge gaps by
1 exploring placental health and cellular ageing in GDM and the association with neonatal outcome
2 evaluating the effectiveness of current and novel maternal health follow-up strategies after GDM
1 exploring placental health and cellular ageing in GDM and the association with neonatal outcome
2 evaluating the effectiveness of current and novel maternal health follow-up strategies after GDM
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None